COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Iute Group reports unaudited 12M 2023 results on 21 February 2024 – Invitation to earnings webcast/call on 22 February 2024
Iute Group reports unaudited 12M 2023 results on 21 February 2024 and invites investors to an earnings webcast/call on 22 February 2024 with CEO and CFO commenting -
-
-
-
-
COMMUNIQUÉ DE PRESSE
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th Congress of European Crohn’s and Colitis Organization (ECCO)
Abivax to present four abstracts on obefazimod for ulcerative colitis at 19th ECCO Congress, including a sponsored symposium on emerging treatment mechanisms. Event details available on ECCO website -
COMMUNIQUÉ DE PRESSE
Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et l’organisation d’un symposium scientifique au 19e congrès de la ECCO
Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et l'organisation d'un symposium scientifique au 19e congrès de la ECCO. Pour plus d'informations, visitez le stand Abivax dans le hall des exposants de l’ECCO -
-
COMMUNIQUÉ RÉGLEMENTÉ
Cie du Bois Sauvage: Buy back of own shares – week from 05/02/2024 to 09/02/2024
Cie du Bois Sauvage announces buy back of own shares from 05/02/2024 to 09/02/2024 in line with authorization from 2021. Details of transactions disclosed including number of shares and total amount
